Friday, May 27, 2016 12:48:41 PM
.... what you have to watch out for,, is this,,, it wasn't a "production contract" in the way investor's want, it to read,,,
"Kraig Biocraft Laboratories Announces Signing Hybrid Silk Production Agreement in Vietnam"
http://www.otcmarkets.com/stock/KBLB/news/Kraig-Biocraft-Laboratories-Announces-Signing-Hybrid-Silk-Production-Agreement-in-Vietnam?id=126292&b=y
... it was a "cooperative agreement",,, most explicitly stated here in the 10K-A,,,.... was kblb management straightforward with the Vietnamese government regarding their "transgenic hybrid silkworms"??,,, the recent indications regarding the BioSafety risk assessment casts some doubt on that.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11291090
" On December 30, 2015, the Company entered into a cooperative agreement for the research and pilot production of hybrid silkworms in Vietnam. Under this agreement the Company will establish a subsidiary in Vietnam where it will develop and produce hybrid silkworms. As of December 31, 2015, the subsidiary was not yet established and no work has been performed in Vietnam for the year ended December 31, 2015. The Company delayed the announcement of this agreement until late in February, 2016. This additional time was used to confirm this agreement with higher level authorities and outside review."
KBLB wasted valuable time,,imo, in not addressing the issues of the Cartagena Protocol,,,some consultation with an experienced individual regarding the requirements of the Cartagena Protocol would have had the issues further ahead.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM